OMRISNI Trademark

Trademark Overview

On Tuesday, October 2, 2018, a trademark application was filed for OMRISNI with the United States Patent and Trademark Office. The USPTO has given the OMRISNI trademark a serial number of 88139957. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 1, 2021. This trademark is owned by Genentech, Inc.. The OMRISNI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neuromuscular diseases and the treatment of muscle weakness
omrisni

General Information

Serial Number88139957
Word MarkOMRISNI
Filing DateTuesday, October 2, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 1, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 29, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neuromuscular diseases and the treatment of muscle weakness

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 10, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenentech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGenentech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, November 1, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 1, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 11, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, August 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 19, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 19, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 19, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, April 19, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 19, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 19, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 10, 2021EXTENSION 4 GRANTED
Wednesday, March 10, 2021EXTENSION 4 FILED
Wednesday, March 10, 2021TEAS EXTENSION RECEIVED
Wednesday, September 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 31, 2020EXTENSION 3 GRANTED
Monday, August 31, 2020EXTENSION 3 FILED
Monday, August 31, 2020TEAS EXTENSION RECEIVED
Wednesday, March 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 2, 2020EXTENSION 2 GRANTED
Monday, March 2, 2020EXTENSION 2 FILED
Monday, March 2, 2020TEAS EXTENSION RECEIVED
Tuesday, September 17, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 13, 2019EXTENSION 1 GRANTED
Friday, September 13, 2019EXTENSION 1 FILED
Friday, September 13, 2019TEAS EXTENSION RECEIVED
Tuesday, March 26, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 29, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 29, 2019PUBLISHED FOR OPPOSITION
Wednesday, January 9, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 19, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 14, 2018ASSIGNED TO EXAMINER
Wednesday, October 10, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, October 5, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

omrisni treatment muscle weakness diseases neuromuscular preparations pharmaceutical